Bortezomib-induced neutrophilic dermatosis with CD30+ lymphocytic infiltration;Toxidermie neutrophilique au bortezomib avec infiltrat de grandes cellules CD30+

Annales de Dermatologie et de Venereologie

Volumn 136, Issue 5, 2009, Pages 438-442

  Petit, A ^a   Thomas, M ^a   Cavelier Balloy, B ^a   Andreoli, A ^b   Briere, J ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Bortezomib; CD30; Drug induced toxicity; Neutrophilic dermatosis; Sweet syndrome

Indexed keywords

ALGINIC ACID; ALLOPURINOL; BLEOMYCIN; BORTEZOMIB; CD30 ANTIGEN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ENOXAPARIN; FUROSEMIDE; IMMUNOGLOBULIN A; METOCLOPRAMIDE; MORPHINE SULFATE; PAMIDRONIC ACID; PANTOPRAZOLE; PREDNISONE; PROCARBAZINE; RECOMBINANT ERYTHROPOIETIN; VALACICLOVIR; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPHOCYTIC INFILTRATION; MYELOMA; RASH; RECURRENT DISEASE; SKIN BIOPSY;

ANTIGENS, CD; ANTIGENS, CD30; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; EXANTHEMA; FEMALE; HUMANS; LYMPHOCYTES; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PYRAZINES; SKIN DISEASES;

EID: 67349217119     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2009.01.011     Document Type: Article

References (14)

1. K.S. Suh, and A. Goy Bortezomib in mantle cell lymphoma Future Oncol 4 2008 149 168
2. C.K. Min, S. Lee, Y.J. Kim, K.S. Eom, J.W. Lee, and W.S. Min Cutaneous leucoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient: association with pro-inflammatory cytokines Eur J Haematol 76 2006 265 268
3. N. Van Regenmortel, K. Van de Voorde, H. De Raeve, S. Rombouts, A. Van de Velde, and J. Lambert Bortezomib-induced Sweet's syndrome Haematologica 90 12 Suppl 2005 ECR43
4. K.L. Wu, F. Heule, K. Lam, and P. Sonneveld Pleomorphic presentation of cutaneous lesions associated with the proteasome inhibitor bortezomib in patients with multiple myeloma J Am Acad Dermatol 55 2006 897 900 (Pubitemid 44556845)
5. X. Garcia-Navarro, L. Puig, M.T. Fernandez-Figueras, J. Dalmau, E. Roe, and A. Alomar Bortezomib-associated cutaneous vasculitis Br J Dermatol 157 2007 799 801 (Pubitemid 47389871)
6. L. Pour, R. Hajek, A. Zdenek, M. Krejci, A. Krivanova, and J. Vorlicek Skin lesions induced by bortezomib Haematologica 90 12 Suppl 2005 ECR44
7. S. Sanchez-Politta, L. Favet, K. Kerl, P.Y. Dietrich, and V. Piquet Bortezomib-induced skin eruption Dermatology 216 2008 156 158
8. N. Scheinfeld A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine J Drugs Dermatol 6 2007 352 355
9. B. Villarrubia, I. Betlloch, J. Mataix, A. Lucas, and C. Botella Bortezomib-associated rash: a new recognizable and avoidable side-effect Br J Dermatol 156 2007 784 785 (Pubitemid 46452375)
10. L. Knoops, A. Jacquemain, D. Tennstedt, I. Theate, A. Ferrant, and E. Van Den Neste Bortezomib-induced Sweet syndrome Br J Haematol 131 2005 142 (Pubitemid 43899678)
11. J. Gerecitano, A. Goy, J. Wright, B. MacGregor-Cortelli, E. Neylon, and M. Gonen Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response? Br J Haematol 134 2006 391 398 (Pubitemid 44079552)
12. S. Mangiacavalli, P. Zappasodi, C. Castagnola, C. Astori, M. Varettoni, and M. Lazzarino Severe intestinal vasculitis in a patient under treatment with bortezomib Ann Hematol 86 2007 923 924
13. W. Kempf CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators J Cutan Pathol 33 2006 58 70
14. L.D. Su, and L.M. Duncan Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions J Cutan Pathol 27 2000 249 254 (Pubitemid 30248968)